Seres Therapeutics (MCRB) FCF Margin (2016 - 2026)
Seres Therapeutics (MCRB) posted FCF Margin of -3042.66% for Q2 2026, up 1527.17 percentage points from the prior quarter.
Powered by 
Analysis
Seres Therapeutics (MCRB) FCF Margin (2016 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, FCF Margin at Seres Therapeutics was -2724.11%; for FY2025, it was 109.63%.
- Annual FCF Margin shows a five-year change of +393.24 percentage points (FY2020 to FY2025).
- In prior years, Seres Therapeutics' FCF Margin was -3347.88% in FY2022 (-3345.90 pp) and -1.99% in FY2021 (+281.62 pp).
- Quarterly FCF Margin has run from a low of -19694.19% in Q3 2023 to a high of 626.21% in Q3 2025 over five years.
- The strongest year-over-year quarter for FCF Margin in the past five years was Q2 2023, with a gain of 4332.45 percentage points; the weakest was Q3 2023, with a drop of 17927.96 percentage points.
- According to Business Quant data, FCF Margin for the three prior quarters was -4569.83% (Q1 2026), -3365.07% (Q4 2025) and 626.21% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.82 Bn | 1,105.41 Bn | 19.71 Bn | 33.76% |
| 2 | Johnson & Johnson | 617.41 Bn | 535.94 Bn | 17.26 Bn | 28.82% |
| 3 | AbbVie | 501.29 Bn | 474.40 Bn | 12.70 Bn | 18.33% |
| 4 | Merck | 368.15 Bn | 322.53 Bn | 12.21 Bn | 26.96% |
| 5 | Novartis Ag | 297.07 Bn | 261.06 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 260.90 Bn | 234.58 Bn | 12.86 Bn | 6.55% |
| 7 | Amgen | 236.34 Bn | 191.74 Bn | 7.24 Bn | 34.70% |
| 8 | Gilead Sciences | 191.00 Bn | 165.20 Bn | 6.22 Bn | 44.00% |
| 9 | Pfizer | 169.72 Bn | 116.36 Bn | 10.94 Bn | 2.01% |
| 10 | Seres Therapeutics | 22.57 Mn | -116.27 Mn | - | -3,042.66% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3,042.66% |
| Mar 31, 2026 | -4,569.83% |
| Dec 31, 2025 | -3,365.07% |
| Sep 30, 2025 | 626.21% |
| Sep 30, 2023 | -19,694.19% |
| Jun 30, 2023 | 51.20% |
| Mar 31, 2023 | -15,450.57% |
| Dec 31, 2022 | -5,779.79% |
| Sep 30, 2022 | -1,766.23% |
| Jun 30, 2022 | -4,281.25% |
| Mar 31, 2022 | -4,648.02% |
| Dec 31, 2021 | -740.08% |
| Sep 30, 2021 | 97.57% |
| Jun 30, 2021 | -802.76% |
| Mar 31, 2021 | -539.31% |
| Dec 31, 2020 | -103.35% |
| Sep 30, 2020 | -1,830.06% |
| Jun 30, 2020 | -426.70% |
| Mar 31, 2020 | -297.01% |
| Dec 31, 2019 | -187.31% |
API Access
Seres Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=MCRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "MCRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=MCRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();